EVALUATION OF IRON CHELATION THERAPY IN β-THALASSEMIA MAJOR PATIENTS IN EAST DELTA OF EGYPT

被引：0
|
作者：
Hassan, T. [1 ]
Badr, M. [1 ]
Hesham, M. [1 ]
Badawy, S. [1 ]
机构：
[1] Zagazig Univ, Zagazig, Egypt
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1810
引用
收藏
页码：701 / 701
页数：1
相关论文
共 50 条
  • [41] Long Term Efficacy Of Iron Chelation Therapy With Deferasirox On Endocrine Function In Thalassemia Major
    Casale, Maddalena
    Citarella, Serena
    Filosa, Aldo
    De Michele, Elisa
    Pugliese, Umberto
    Francesco, Palmieri
    Ragozzino, Alfonso
    Giovanni, Amendola
    Tartaglione, Immacolata
    Della Rocca, Milena
    Nobili, Bruno
    Silverio, Perrotta
    [J]. BLOOD, 2013, 122 (21)
  • [42] Hypoparathyroidism in children with beta-thalassemia major and its relation to iron chelation therapy
    El-Din, Lerine Bahy
    Ebeid, Fatma S. E.
    Toaima, Nadin N.
    Ibrahim, Walaa W.
    [J]. EGYPTIAN JOURNAL OF HAEMATOLOGY, 2018, 43 (02): : 63 - 68
  • [43] Long-term effects of combined chelation therapy in thalassemia major patients with iron-induced cardiomyopathy
    Pepe, A.
    Grady, R.
    Vacquer, S.
    Carta, P.
    Sau, F.
    Bina, P.
    Cianciulli, P.
    Maggio, A.
    Lombardi, M.
    Lai, M. E.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 51 - 51
  • [44] Iron Chelation Therapy in Transfusion Dependent Patients with Thalassemia and Minimal Liver Iron Load
    Kattamis, Antonios
    Stokidis, Konstantinos
    Petropoulou, Tbeoni
    Kyriacopoulou, Dimitra
    Delaporta, Polyxeni
    Papassptiriou, Ioannis
    Ladis, Vassilis
    [J]. BLOOD, 2010, 116 (21) : 1733 - 1733
  • [45] Chelation therapy and bone metabolism markers in thalassemia major
    Pratelli, Loredana
    Verri, Elisabetta
    Fortini, Monica
    Marconi, Stefano
    Zolezzi, Carola
    Fornasari, Pier Maria
    Gamberini, Maria Rita
    De Sanctis, Vincenzo
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2006, 19 (11): : 1335 - 1342
  • [46] A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major
    Fernandes, Juliano L.
    Loggetto, Sandra R.
    Verissimo, Monica P. A.
    Fertrin, Kleber Y.
    Baldanzi, Giorgio R.
    Fioravante, Luciana A. B.
    Tan, Doralice M.
    Higa, Tatiana
    Mashima, Denise A.
    Piga, Antonio
    Coelho, Otavio R.
    Costa, Fernando F.
    Saad, Sara T.
    [J]. BLOOD, 2016, 128 (12) : 1555 - 1561
  • [47] Iron chelation with oral deferiprone in patients with thalassemia
    Nathan, DG
    Weatherall, DJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23): : 1711 - 1712
  • [48] Longitudinal analysis of heart and liver iron in thalassemia major patients according to chelation treatment
    Danjou, F.
    Origa, R.
    Anni, F.
    Saba, L.
    Cossa, S.
    Podda, G.
    Galanello, R.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2013, 51 (03) : 142 - 145
  • [49] Can Oral Iron Chelation Therapies Reduce Endocrine Complications in β-Thalassemia Major Patients?
    Rostami, Parastoo
    Mohsenipour, Reyhaneh
    Khoshkbarforoshan, Mina
    Sayarifard, Fatemeh
    Setoudeh, Arya
    Safari, Alieh
    Kompani, Farzad
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 481 - 481
  • [50] EVALUATION OF THE EFFECTIVENESS OF CHELATION-THERAPY IN THALASSEMIA
    MAURER, HS
    LLOYDSTILL, JD
    INGRISANO, C
    KUSHNER, JP
    CRUSSI, F
    HONIG, G
    [J]. HEPATOLOGY, 1985, 5 (05) : 1030 - 1030
12345